CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Planned sale Director sold 46,808 shares at an average $355.31 ($16,631,386)
- 4 Planned sale Director sold 46,463 shares at an average $355.32 ($16,509,032)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 967 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Planned sale Director sold 1,000 shares at $350.01 ($350,005)
- 4 Planned sale Director sold 1,400 shares at $350.03 ($490,044)
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 28,876 shares at an average $353.19 ($10,198,844)
- 4 Planned sale Director sold 29,101 shares at an average $353.19 ($10,278,098)
- 144 Insider Sale of Securities
Page 7 of 62 · 1,224 filings